학술논문
Ibrutinib Plus Venetoclax with MRD-Directed Duration of Treatment Is Superior to FCR and Is a New Standard of Care for Previously Untreated CLL: Report of the Phase III UK NCRI FLAIR Study
Document Type
Journal
Author
Hillmen, Peter; Cairns, David Allan; Bloor, Adrian John Clifton; Allsup, David; Cwynarski, Kate; Pettitt, Andrew; Paneesha, Shankaranarayana; Fox, Christopher P.; Eyre, Toby A.; Forconi, Francesco; Elmusharaf, Nagah; Kennedy, Ben; Gribben, John G.; Pemberton, Nicholas; Sheehy, Oonagh; Preston, Gavin; Schuh, Anna; Howard, Dena; Hockaday, Anna; Jackson, Sharon; Greatorex, Natasha; Girvan, Sean; Bell, Sue; Brown, Julia; Webster, Nichola; Dalal, Surita; de Tute, Ruth M.; Rawstron, Andrew; Patten, Piers E. M.; Munir, Talha
Source
Subject
Language
English
ISSN
15280020